Clinical Trial Update: Folfiri as Third Line of Treatment

View source ↗

Summary

Clinical trial evaluating the FOLFIRI regimen as a third-line treatment for gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: IRCCS Cancer Referral Center of Basilicata | Conditions: Gastric Cancer, Ramucirumab | Status: COMPLETED